Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | BBLN | Class A ordinary shares | 3.32M | Dec 30, 2022 | See footnote | F1 | |||||
holding | BBLN | Class A ordinary shares | 710K | Dec 30, 2022 | See footnote | F2 |
Id | Content |
---|---|
F1 | These Class A ordinary shares (the "Shares") are owned directly by VNV (Cyprus) Limited ("VNV Cyprus"). VNV Cyprus is a wholly-owned subsidiary of VNV Global AB (publ) ("VNV Global"). VNV Global may be deemed to beneficially own the Shares held by VNV Cyprus. |
F2 | These Shares are owned directly by Global Health Equity (Cyprus) Ltd ("Global Health Equity"). VNV Global indirectly holds, through its direct wholly-owned subsidiary, VNV Sweden AB ("VNV Sweden"), approximately 37.3521% of the shares in Global Health Equity AB (publ) ("Global Health (publ)"), the direct and sole shareholder of Global Health Equity, with the remainder held by other foreign institutional investors and individuals. VNV Global may be deemed to beneficially own the Shares held by Global Health Equity. |